189 results on '"Stetler-Stevenson, William"'
Search Results
2. Tissue inhibitors of metalloproteinases are proteolytic targets of matrix metalloproteinase 9
3. The Continuing Saga of Tissue Inhibitor of Metalloproteinase 2: Emerging Roles in Tissue Homeostasis and Cancer Progression
4. Whole organism profiling of the Timp gene family
5. Inhibition of Hepatic Stellate Cell Activation Suppresses Tumorigenicity of Hepatocellular Carcinoma in Mice
6. The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect
7. Mapping Extracellular Protein–Protein Interactions Using Extracellular Proximity Labeling (ePL).
8. Co-chaperones TIMP2 and AHA1 Competitively Regulate Extracellular HSP90:Client MMP2 Activity and Matrix Proteolysis
9. Extracellular Phosphorylation of TIMP-2 by Secreted c-Src Tyrosine Kinase Controls MMP-2 Activity
10. The TIMP protein family: diverse roles in pathophysiology.
11. Induction of Cell Migration by Matrix Metalloprotease-2 Cleavage of Laminin-5
12. Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 Inhibitors
13. c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer Cells
14. Human cardiac fibroblast extracellular matrix remodeling: dual effects of tissue inhibitor of metalloproteinase-2
15. Asymmetric Hsp90 N Domain SUMOylation Recruits Aha1 and ATP-Competitive Inhibitors
16. Antagonism of VEGF-A–induced increase in vascular permeability by an integrin α3β1-Shp-1-cAMP/PKA pathway
17. Matrix Metalloproteinases: Changing Roles in Tumor Progression and Metastasis
18. Expression of soluble and functional full-length human matrix metalloproteinase-2 in Escherichia coli
19. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo
20. Endogenous Angiogenesis Inhibitor Blocks Tumor Growth via Direct and Indirect Effects on Tumor Microenvironment
21. TIMP-2 modulates VEGFR-2 phosphorylation and enhances phosphodiesterase activity in endothelial cells
22. Swe1 Wee1-Dependent Tyrosine Phosphorylation of Hsp90 Regulates Distinct Facets of Chaperone Function
23. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
24. Role of the α v β 3 Integrin in Human Melanoma Cell Invasion
25. TIMP-2 disrupts FGF-2-induced downstream signaling pathways
26. Hematopoiesis in mice is extremely resilient to wide variation in TIMP/MMP balance
27. TIMP1 induces CD44 expression and the activation and nuclear translocation of SHP1 during the late centrocyte/post-germinal center B cell differentiation
28. Dietary intake of a plant phospholipid/lipid conjugate reduces lung cancer growth and tumor angiogenesis
29. The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
30. Tissue inhibitor of matrix metalloproteinase-1 overexpression in M1 myeloblasts impairs IL-6-induced differentiation
31. Shp-1 Mediates the Antiproliferative Activity of Tissue Inhibitor of Metalloproteinase-2 in Human Microvascular Endothelial Cells
32. TIMP-2 promotes cell spreading and adhesion via upregulation of Rap1 signaling
33. Matrix metalloproteinases and metastasis
34. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activityin vivo
35. Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis
36. Novel anti-filamin-A antibody detects a secreted variant of filamin-A in plasma from patients with breast carcinoma and high-grade astrocytoma
37. CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells
38. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors
39. TIMP-2: an endogenous inhibitor of angiogenesis
40. Unravelling the distinct biological functions and potential therapeutic applications of TIMP2 in cancer.
41. Activation of the Estrogen Receptor Contributes to the Progression of Pulmonary Lymphangioleiomyomatosis via Matrix Metalloproteinase-Induced Cell Invasiveness
42. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas
43. Expression and localization of 72 kDa type IV collagenase (MMP-2) in human malignant gliomas in vivo
44. Expression of 72 kDa and 92 kDa type IV collagenases from human giant-cell tumor of bone
45. Expression of tissue inhibitors of metalloproteinases: negative regulators of human glioblastoma invasion in vivo
46. Role of plasminogen activator and of 92-KDa type IV collagenase in glioblastoma invasion using anin vitro Matrigel model
47. Role of Human Cripto-1 in Tumor Angiogenesis
48. Type IV collagenases in tumor invasion and metastasis
49. TIMP-2 Mediated Inhibition of Angiogenesis: An MMP-Independent Mechanism
50. Quantitative Assessment of Angiogenic Responses by the Directed in Vivo Angiogenesis Assay
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.